Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study - Stenlöf, K; Cefalu, W T; Kim, K A (Curr Med Res Opin, 2014)